Difference between revisions of "Avatrombopag (Doptelet)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m
Line 7: Line 7:
  
 
==History of changes in FDA indication==
 
==History of changes in FDA indication==
* 5/21/2018: Approved for [[Thrombocytopenia in liver disease|thrombocytopenia in adults with chronic liver disease]] scheduled to undergo a procedure.
+
* 2018-05-21: Approved for [[Thrombocytopenia in liver disease|thrombocytopenia in adults with chronic liver disease]] scheduled to undergo a procedure.
 
==History of changes in EMA indication==
 
==History of changes in EMA indication==
*6/20/2019: Initial authorization as Doptelet
+
*2019-06-20: Initial authorization as Doptelet
*Doptelet is indicated for the treatment of severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.
+
*Uncertain date: Doptelet is indicated for the treatment of severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.
*Doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).
+
*Uncertain date: Doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).
  
 
==Also known as==
 
==Also known as==

Revision as of 16:47, 9 May 2023

Mechanism of action

Thrombopoietin receptor agonist

Diseases for which it is established

History of changes in FDA indication

History of changes in EMA indication

  • 2019-06-20: Initial authorization as Doptelet
  • Uncertain date: Doptelet is indicated for the treatment of severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.
  • Uncertain date: Doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).

Also known as

  • Code names: E5501, YM477, AKR 501
  • Brand name: Doptelet